Procrit
Procrit Side Effects May Lead To Heart Attack Lawsuits
Procrit Side Effects Lead To Heart Attack Lawsuits. New Article Latest Procrit Drug Warning. On November 30, 2006, reports came out that two studies in this month's New England Journal of Medicine have called into question the overuse of drugs in the treatment of anemia in kidney patients. Johnson & Johnson's Procrit … [Read more...] about Procrit Side Effects May Lead To Heart Attack Lawsuits
Procrit, Similar Drugs Linked to Increased Death Risk
Procrit And Other Similar Drugs Increased Death Risk. Two more studies have found that anemia drugs like Epogen, Procrit and Aranesp raise the risk of death among cancer patients. Despite known safety risks, drugs like Procrit continue to be used because it is believed that they help reduce the number of blood transfusions some … [Read more...] about Procrit, Similar Drugs Linked to Increased Death Risk
American Children Take the Most Psychotropic Drugs
Most Psychotropic Drugs. A new study reports that American children are about three times likelier to be prescribed psychotropic medications than children in Europe. The study states that the differences may be attributable to regulatory practices and cultural beliefs about the role of medication in emotional and behavioral … [Read more...] about American Children Take the Most Psychotropic Drugs
New Labeling for Procrit, Aranesp and Epogen
Procrit, Aranesp and Epogen New Label. FDA Forces New Labeling, Federal regulators have decided that the anemia drugs Aranesp, Epogen and Procrit need to have additional safety-related changes to their labels. The changes mandated by the Food & Drug Administration (FDA) would restrict the use of the drugs in some … [Read more...] about New Labeling for Procrit, Aranesp and Epogen
Procrit, Epogen and Aranesp Marketing Investigation
Procrit, Epogen Marketing Investigation. Two members of Congress are looking into to allegations that the marketing of Procrit, Aranesp and Epogen encouraged overuse of the anemia drugs, placing some patients in danger. Reps. John Dingell and Bart Stupak, both Michigan Democrats, sent letters to Amgen and Johnson & Johnson on … [Read more...] about Procrit, Epogen and Aranesp Marketing Investigation
Procrit, Aranesp, Epogen Restricted by FDA
Procrit, Aranesp, Epogen. Procrit, Aranesp and Epogen, anemia drugs used to treat chemotherapy patients, could soon have new restrictions imposed on them by the Food and Drug Administration (FDA). Late last week, the FDA announced a new black box warning for Procrit, Aranesp and Epogen regarding their association with shortened … [Read more...] about Procrit, Aranesp, Epogen Restricted by FDA
